26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00463567 · COMPLETED

Trial details

NCT number: NCT00463567
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive COPD Lung Diseases, Obstructive

Start date: 2007-04-01
Primary completion: 2008-08-01
Enrollment: 2059

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.